Prepn: C. L. Zirkle, US 3131190 (1964 to SKF). Effect on in vivo histamine metabolism: R. Schayer, M. A. Reilly, Arch. Int. Pharmacodyn. Ther. 203, 123 (1973). Clinical potency in relation to dopamine-binding: P. Seeman et al., Nature 261, 717 (1976). Pharmacology: P. Fowler et al., Arzneim.-Forsch. 27, 866 (1977). Photooxidation study: W. R. Knappe, J. Pharm. Sci. 67, 318 (1978).
Antipsychotic.
Antipsychotic; Other Tricyclics
This monograph has been retired and is no longer subject to revision or update.